Pharmaceutical marketing and the invention of the medical consumer.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

21 citing papers in PubMed.

1. Public health, primary healthcare, and "corporatization" of health.Journal of family medicine and primary care · 2025
   Article
2. Beyond the regulatory radar: knowledge and practices of rural medical practitioners in Bangladesh.BMC health services research · 2023
   Article
3. Psychiatrization of Society: A Conceptual Framework and Call for Transdisciplinary Research.Frontiers in psychiatry · 2021
   Review
4. Neuronarratives of Affliction: Antidepressants, Neuropolitics and the "Entrepreneur of Oneself".Culture, medicine and psychiatry · 2020
   Article
5. Why Psychiatry Needs the Anthropologist: A Reflection on 80 Years of Culture in Mental Health.Psychiatry · 2019
   Article
6. Using the Advocacy Coalition Framework to understand EU pharmaceutical policy.European journal of public health · 2018
   Article
7. Strategies for patient empowerment through the promotion of medicines in Israel: regulatory framework for the pharmaceutical industry.Israel journal of health policy research · 2017
   Article
8. Can a good tree bring forth evil fruit? The funding of medical research by industry.British medical bulletin · 2016
   Review
9. "Just Advil": Harm reduction and identity construction in the consumption of over-the-counter medication for chronic pain.Social science & medicine (1982) · 2015
   Article
10. Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine.World medical & health policy · 2015
    Article
11. Beyond critique: rethinking roles for the anthropology of mental health.Culture, medicine and psychiatry · 2014
    Article
12. Deep pharma: psychiatry, anthropology, and pharmaceutical detox.Culture, medicine and psychiatry · 2014
    Article
13. The dominance of big pharma: power.Medicine, health care, and philosophy · 2013
    Article
14. ["Prescription upon request" or "determining demand"? On the perception of the tranquiliser-consumer in the GDR (1960-1970)].NTM · 2013
    Article
15. ["In a Socialist State it Should be Possible for Activists like me to Receive Effective Medication." Psychotropic Drugs and Consumer Interests in the GDR].NTM · 2013
    Article
16. Social but safe? Quality and safety of diabetes-related online social networks.Journal of the American Medical Informatics Association : JAMIA · 2011
    Article
17. The creation of the health consumer: challenges on health sector regulation after managed care era.Globalization and health · 2011
    Article
18. Getting to yes: corporate power and the creation of a psychopharmaceutical blockbuster.Culture, medicine and psychiatry · 2009
    Article
19. The role of medical language in changing public perceptions of illness.PloS one · 2008
    Article
20. Disease mongering -- a challenge for everyone involved in healthcare.British journal of clinical pharmacology · 2007
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as